Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024 2024-09-14 16:06
Harbour BioMed Reports Full Year 2023 Financial Results 2024-03-28 22:10
Harbour BioMed Announces Positive Profit Alert 2024-01-19 12:52
1